FDA submissions are underway for lowerrespiratory tract disease, asthma andprimary upper respiratory tract disease. Does anyone know if this has significant commercial potential ?
- Forums
- ASX - By Stock
- RAP
- Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study
Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study, page-237
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)